Antiviral medications for hepatitis, HIV, and viral infections
Among pregnant women, the antiviral drug cocktail ledipasvir/sofosbuvir resulted in 100% hepatitis C cure rate, revealed study published today in The Lancet Microbe. None of their babies contracted the virus and they…
Continue Reading
New Antiviral Drug Cocktail Safe and Effective In Treating Hep-C During Pregnancy
An inexpensive two-drug regimen of sofosbuvir (Sovaldi, Gilead Sciences) plus daclatasvir (Daklinza, Bristol-Myers Squibb) taken for 14 days significantly reduced time to recovery from COVID-19 and improved survival in people hospitalized with severe disease,…
Continue Reading
Hep C Sofosbuvir/Daclatasvir Combo Promising for COVID-19
The US Food and Drug Administration has approved fostemsavir (Rukobia, ViiV Healthcare), a first-in-class attachment inhibitor for the treatment of HIV-1 infection in adults. Fostemsavir is indicated for use in…
Continue Reading
FDA OKs First-in-Class HIV Therapy for Patients With Few Options
The US Food and Drug Administration (FDA) has approved the first dispersible tablet formulation of dolutegravir (Tivicay PD, ViiV Healthcare) to treat HIV-1 infection in children at least 4 weeks old and…
Continue Reading
FDA OKs First Dispersible Form of Dolutegravir for Infants
First recognized in 1988, World AIDS Day falls on December 1 each year. World AIDS Day is dedicated to spreading awareness of the AIDS pandemic spread by the spread of…